Publications

  1. Luckey D, Behrens M, Smart M, Luthra H, David CS, Taneja V. DRB1*0402 may influence arthritis by promoting naive CD4 T-cell differentiation in to regulatory T cells. Eur J Immunol. 2014 Aug 07.
    View PubMed
  2. Vassallo R, Luckey D, Behrens M, Madden B, Luthra H, David C, Taneja V. Cellular and humoral immunity in arthritis are profoundly influenced by the interaction between cigarette smoke effects and host HLA-DR and DQ genes. Clin Immunol. 2014 May-Jun; 152(1-2):25-35. Epub 2014 Feb 14.
    View PubMed
  3. Behrens M, Smart M, Luckey D, Luthra H, Taneja V. To B or not to B: role of B cells in pathogenesis of arthritis in HLA transgenic mice. J Autoimmun. 2011 Sep; 37(2):95-103. Epub 2011 Jun 12.
    View PubMed
  4. Behrens M, Papadopoulos GK, Moustakas A, Smart M, Luthra H, David CS, Taneja V. Trans heterodimer between two non-arthritis-associated HLA alleles can predispose to arthritis in humanized mice. Arthritis Rheum. 2011 Jun; 63(6):1552-61.
    View PubMed
  5. Kermani TA, Crowson CS, Achenbach SJ, Luthra HS. Idiopathic retroperitoneal fibrosis: a retrospective review of clinical presentation, treatment, and outcomes. Mayo Clin Proc. 2011 Apr; 86(4):297-303.
    View PubMed
  6. Akkara Veetil BM, Luthra H. Erdheim-Chester disease. Clin Rheumatol. 2011 Mar; 30(3):397-8. Epub 2010 Oct 15.
    View PubMed
  7. Behrens M, Trejo T, Luthra H, Griffiths M, David CS, Taneja V. Mechanism by which HLA-DR4 regulates sex-bias of arthritis in humanized mice. J Autoimmun. 2010 Aug; 35(1):1-9. Epub 2010 Jan 12.
    View PubMed
  8. Kumar N, Sandroni P, Steensma DP, Luthra HS, Habermann TM. Polyradiculopathy due to methotrexate-induced ebv-associated lymphoproliferative disorder. Neurology. 2008 Nov 11; 71(20):1644-5.
    View PubMed
  9. Taneja V, Behrens M, Basal E, Sparks J, Griffiths MM, Luthra H, David CS. Delineating the role of the HLA-DR4 "shared epitope" in susceptibility versus resistance to develop arthritis. J Immunol. 2008 Aug 15; 181(4):2869-77.
    View PubMed
  10. Kermani TA, Luthra HS. Folate supplementation and methotrexate in treatment of rheumatoid arthritis. Indian Journal of Rheumatology. 2008; 3(2):77-9.
    View PubMed
  11. Chowdhary VR, Grande JP, Luthra HS, David CS. Characterization of haemorrhagic pulmonary capillaritis: another manifestation of Pristane-induced lupus. Rheumatology (Oxford). 2007 Sep; 46(9):1405-10. Epub 2007 Jun 18.
    View PubMed
  12. Taneja V, Krco CJ, Behrens MD, Luthra HS, Griffiths MM, David CS. B cells are important as antigen presenting cells for induction of MHC-restricted arthritis in transgenic mice. Mol Immunol. 2007 Apr; 44(11):2988-96. Epub 2007 Feb 14.
    View PubMed
  13. Taneja V, Behrens M, Mangalam A, Griffiths MM, Luthra HS, David CS. New humanized HLA-DR4-transgenic mice that mimic the sex bias of rheumatoid arthritis. Arthritis Rheum. 2007 Jan; 56(1):69-78.
    View PubMed
  14. Cauduro SA, Moder KG, Luthra HS, Seward JB. Echocardiographically guided pericardiocentesis for treatment of clinically significant pericardial effusion in rheumatoid arthritis. J Rheumatol. 2006 Nov; 33(11):2173-7.
    View PubMed
  15. Chowdhry V, Kumar N, Lachance DH, Salomao DR, Luthra HS. An unusual presentation of rheumatoid meningitis. J Neuroimaging. 2005 Jul; 15(3):286-8.
    View PubMed
  16. Taneja V, Taneja N, Behrens M, Griffiths MM, Luthra HS, David CS. Requirement for CD28 may not be absolute for collagen-induced arthritis: study with HLA-DQ8 transgenic mice. J Immunol. 2005 Jan 15; 174(2):1118-25.
    View PubMed
  17. Kent PD, Luthra HS, Michet C Jr. Risk factors for methotrexate-induced abnormal laboratory monitoring results in patients with rheumatoid arthritis. J Rheumatol. 2004 Sep; 31(9):1727-31.
    View PubMed
  18. Kent PD, Michet CJ Jr, Luthra HS. Relapsing polychondritis. Curr Opin Rheumatol. 2004 Jan; 16(1):56-61.
    View PubMed
  19. Tripuraneni R, Houghton SG, Luthra HS, Grogg KL, vanHeerden JA. What can be done for a woman with ‘holes’ in her spleen? Contemporary Surgery. 2004; 60(9):418-22.
    View PubMed
  20. Siegel JL, Luthra H, Donlinger J, Angulo P, Lindor K. Association of primary biliary cirrhosis and rheumatoid arthritis. J Clin Rheumatol. 2003 Dec; 9(6):340-3.
    View PubMed
  21. Taneja V, Griffiths M, Behrens M, Luthra HS, David CS. Auricular chondritis in NOD.DQ8.Abetao (Ag7-/-) transgenic mice resembles human relapsing polychondritis. J Clin Invest. 2003 Dec; 112(12):1843-50.
    View PubMed
  22. Taneja V, Taneja N, Behrens M, Pan S, Trejo T, Griffiths M, Luthra H, David CS. HLA-DRB1*0402 (DW10) transgene protects collagen-induced arthritis-susceptible H2Aq and DRB1*0401 (DW4) transgenic mice from arthritis. J Immunol. 2003 Oct 15; 171(8):4431-8.
    View PubMed
  23. Klos K, Flemming KD, Petty GW, Luthra HS. Takayasu's arteritis with arteriographic evidence of intracranial vessel involvement. Neurology. 2003 May 13; 60(9):1550-1.
    View PubMed
  24. Moder KG, Gaffey TA, Luthra HS. A smoker with a pulmonary nodule and progressive neurologic deficits... Wegener granulomatosis, fortieth in a series. J Musculoskeletal Med. 2003 May; 20(5):251-3.
    View PubMed
  25. Bidaut-Russell M, Gabriel SE, Scott CG, Zinsmeister AR, Luthra HS, Yawn B. Determinants of patient satisfaction in chronic illness. Arthritis Rheum. 2002 Oct 15; 47(5):494-500.
    View PubMed
  26. Taneja V, Taneja N, Paisansinsup T, Behrens M, Griffiths M, Luthra H, David CS. CD4 and CD8 T cells in susceptibility/protection to collagen-induced arthritis in HLA-DQ8-transgenic mice: implications for rheumatoid arthritis. J Immunol. 2002 Jun 1; 168(11):5867-75.
    View PubMed
  27. Paisansinsup T, Deshmukh US, Chowdhary VR, Luthra HS, Fu SM, David CS. HLA class II influences the immune response and antibody diversification to Ro60/Sjogren's syndrome-A: Heightened antibody responses and epitope spreading in mice expressing HLA-DR molecules. J Immunol. 2002 Jun 1; 168(11):5876-84.
    View PubMed
  28. Paisansinsup T, Vallejo AN, Luthra H, David CS. HLA-DR modulates autoantibody repertoire, but not mortality, in a humanized mouse model of systemic lupus erythematosus. J Immunol. 2001 Oct 1; 167(7):4083-90.
    View PubMed
  29. Gabriel SE, Wagner JL, Zinsmeister AR, Scott CG, Luthra HS. Is rheumatoid arthritis care more costly when provided by rheumatologists compared with generalists? Arthritis Rheum. 2001 Jul; 44(7):1504-14.
    View PubMed
  30. Khare SD, Lee S, Bull MJ, Hanson J, Luthra HS, David CS. Spontaneous inflammatory disease in HLA-B27 transgenic mice does not require transporter of antigenic peptides. Clin Immunol. 2001 Mar; 98(3):364-9.
    View PubMed
  31. Wasserman SI, Kimball HR, Duffy FD, and for the Task Force on Recertification. Recertification in internal medicine: a program of continuous professional development. Ann Intern Med. 2000 Aug 1; 133(3):202-8.
    View PubMed
  32. Lee S, Khare SD, Griffiths MM, Luthra HS, David CS. HLA-B27 transgenic mice are susceptible to collagen-induced arthritis: type II collagen as a potential target in human disease. Hum Immunol. 2000 Feb; 61(2):140-7.
    View PubMed
  33. Menke DM, Griesser H, Moder KG, Tefferi A, Luthra HS, Cohen MD, Colon-Otero G, Lloyd RV. Lymphomas in patients with connective tissue disease. Comparison of p53 protein expression and latent EBV infection in patients immunosuppressed and not immunosuppressed with methotrexate. Am J Clin Pathol. 2000 Feb; 113(2):212-8.
    View PubMed
  34. Pan S, Taneja V, Griffiths MM, Luthra H, David CS. Complementation between HLA-DR4 (DRB1*0401) and specific H2-A molecule in transgenic mice leads to collagen-induced arthritis. Hum Immunol. 1999 Sep; 60(9):816-25.
    View PubMed
  35. Krco CJ, Watanabe S, Harders J, Griffths MM, Luthra H, David CS. Identification of T cell determinants on human type II collagen recognized by HLA-DQ8 and HLA-DQ6 transgenic mice. J Immunol. 1999 Aug 1; 163(3):1661-5.
    View PubMed
  36. Das P, Bradley DS, Geluk A, Griffiths MM, Luthra HS, David CS. An HLA-DRB1*0402 derived peptide (HV3 65-79) prevents collagen-induced arthritis in HLA-DQ8 transgenic mice. Hum Immunol. 1999 Jul; 60(7):575-82.
    View PubMed
  37. Gabriel SE, Crowson CS, Luthra HS, Wagner JL, O'Fallon WM. Modeling the lifetime costs of rheumatoid arthritis. J Rheumatol. 1999 Jun; 26(6):1269-74.
    View PubMed
  38. Khare SD, Lee S, Bull MJ, Hanson J, Luthra HS, Hammerling GJ, David CS. Peptide binding alpha1alpha2 domain of HLA-B27 contributes to the disease pathogenesis in transgenic mice. Hum Immunol. 1999 Feb; 60(2):116-26.
    View PubMed
  39. Bradley DS, Das P, Griffiths MM, Luthra HS, David CS. HLA-DQ6/8 double transgenic mice develop auricular chondritis following type II collagen immunization: a model for human relapsing polychondritis. J Immunol. 1998 Nov 1; 161(9):5046-53.
    View PubMed
  40. Khare SD, Luthra HS, David CS. Animal models of human leukocyte antigen B27-linked arthritides. Rheum Dis Clin North Am. 1998 Nov; 24(4):883-94, xi-xii.
    View PubMed
  41. Taneja V, Griffiths MM, Luthra H, David CS. Modulation of HLA-DQ-restricted collagen-induced arthritis by HLA-DRB1 polymorphism. Int Immunol. 1998 Oct; 10(10):1449-57.
    View PubMed
  42. Khare SD, Luthra HS, David CS. Unraveling the mystery of HLA-B27 association with human spondyloarthropathies using transgenic and knock out mice. Semin Immunol. 1998 Feb; 10(1):15-23.
    View PubMed
  43. Khare SD, Bull MJ, Hanson J, Luthra HS, David CS. Spontaneous inflammatory disease in HLA-B27 transgenic mice is independent of MHC class II molecules: a direct role for B27 heavy chains and not B27-derived peptides. J Immunol. 1998 Jan 1; 160(1):101-6.
    View PubMed
  44. Khare SD, Luthra HS, David CS. HLA-B27 and other predisposing factors in spondyloarthrapathies. Curr Opin Rheumatol. 1998; 10(4):282-291.
    View PubMed
  45. Bradley DS, Nabozny GH, Cheng S, Zhou P, Griffiths MM, Luthra HS, David CS. HLA-DQB1 polymorphism determines incidence, onset, and severity of collagen-induced arthritis in transgenic mice. Implications in human rheumatoid arthritis. J Clin Invest. 1997 Nov 1; 100(9):2227-34.
    View PubMed
  46. Taneja V, Hansen J, Smart M, Griffiths M, Luthra H, David CS. Expression of the H2-E molecule mediates protection to collagen-induced arthritis in HLA-DQ8 transgenic mice: role of cytokines. Int Immunol. 1997 Aug; 9(8):1213-9.
    View PubMed
  47. Khare SD, Hansen J, Luthra HS, David CS. HLA-B27 heavy chains contribute to spontaneous inflammatory disease in B27/human beta2-microglobulin (beta2m) double transgenic mice with disrupted mouse beta2m. J Clin Invest. 1996 Dec 15; 98(12):2746-55.
    View PubMed
  48. Gonzalez-Gay MA, Zanelli E, Khare SD, Krco CJ, Zhou P, Inoko H, Griffiths MM, Luthra HS, David CS. Human leukocyte antigen-DRB1*1502 (DR2Dw12) transgene reduces incidence and severity of arthritis in mice. Hum Immunol. 1996 Sep 15; 50(1):54-60.
    View PubMed
  49. Krco CJ, Pawelski J, Harders J, McCormick D, Griffiths M, Luthra HS, David CS. Characterization of the antigenic structure of human type II collagen. J Immunol. 1996 Apr 15; 156(8):2761-8.
    View PubMed
  50. Nabozny GH, Baisch JM, Cheng S, Cosgrove D, Griffiths MM, Luthra HS, David CS. HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis. J Exp Med. 1996 Jan 1; 183(1):27-37.
    View PubMed
  51. Khare SD, Luthra HS, David CS. Role of HLA-B27 in spondyloarthropathies. Curr Top Microbiol Immunol. 1996; 206:85-100.
    View PubMed
  52. Gonzalezgay MA, Zanelli E, Khare SD, Krco CJ, Griffiths MM, Luthra HS, David CS. Polymorphism contributes to H2-E-beta-mediated protection in collagen-induced arthritis. Immunogenetics. 1996; 44(5):377-384.
    View PubMed
  53. Khare SD, Krco CJ, Griffiths MM, Luthra HS, David CS. Oral administration of an immunodominant human collagen peptide modulates collagen-induced arthritis. J Immunol. 1995 Oct 1; 155(7):3653-9.
    View PubMed
  54. Khare SD, Luthra HS, David CS. Spontaneous inflammatory arthritis in HLA-B27 transgenic mice lacking beta 2-microglobulin: a model of human spondyloarthropathies. J Exp Med. 1995 Oct 1; 182(4):1153-8.
    View PubMed
  55. Moder KG, Gaffey TA, Luthra HS. Musculoskeletal radiology quiz. A smoker with a pulmonary nodule and progressive neurologic deficits. J Musculoskeletal Med. 1995 Oct; 12(10):71-2, 74.
  56. Moder KG, Tefferi A, Cohen MD, Menke DM, Luthra HS. Hematologic malignancies and the use of methotrexate in rheumatoid arthritis: a retrospective study. Am J Med. 1995 Sep; 99(3):276-81.
    View PubMed
  57. David CS, Nabozny GH, Gonzalez-Gay M, Zanelli E, Griffiths M, Luthra H. Polymorphism in the HLA-DQ locus determines susceptibility and polymorphism in the HLA-DR beta 1 genes determine protection in collagen induced arthritis: implications in human rheumatoid arthritis. Ann Rheum Dis. 1995 Sep; 54(9):760-761.
  58. Nabozyny GH, Rimm IJ, Griffiths MM, Luthra HS, David CS. Expression of an ovalbumin-specific V(beta)8.2 TCR transgene inhibits collagen arthritis in B10.Q mice. Int Immunol. 1995 Aug; 7:1279-1286.
    View PubMed
  59. Nabozny GH, Griffiths MM, Rimm IJ, Luthra HS, David CS. Effect of constrained T-cell receptor repertoires on collagen-induced arthritis in T-cell receptor V beta transgenic and congenic mice. Ann N Y Acad Sci. 1995 Jul 7; (756):217-20.
  60. Nabozny GH, Hanson J, Griffiths MM, Luthra HS, David CS. Altered development of collagen induced arthritis in T cell receptor V beta congenic B10.RIII mice. Autoimmunity. 1995; 20(1):51-8.
    View PubMed
  61. Nabozny GH, Griffiths MM, Harper DS, Luthra HS, David CS. Identification of a cyanogen bromide fragment of porcine type II collagen capable of modulating collagen arthritis in B10.RIII (H-2r) mice. Autoimmunity. 1995; 20(1):39-49.
    View PubMed
  62. Gonzalez-Gay MA, Zanelli E, Krco CJ, Nabozny GH, Hanson J, Griffiths MM, Luthra HS, David CS. Polymorphism of the MHC class II Eb gene determines the protection against collagen-induced arthritis. Immunogenetics. 1995; 42(1):35-40.
    View PubMed
  63. Gonzalez-Gay MA, Nabozny GH, Bull MJ, Zanelli E, Douhan J 3rd, Griffiths MM, Glimcher LH, Luthra HS, David CS. Protective role of major histocompatibility complex class II Ebd transgene on collagen-induced arthritis. J Exp Med. 1994 Oct 1; 180(4):1559-64.
    View PubMed
  64. Griffiths MM, Nabozny GH, Hanson J, Harper DS, McCall S, Moder KG, Cannon GW, Luthra HS, David CS. Collagen-induced arthritis and TCRs in SWR and B10.Q mice expressing an e (alpha) (k) transgene. J Immunol. 1994 Sep 15; 153:2758-2768.
    View PubMed
  65. Nabozny GH, Bull MJ, Hanson J, Griffiths MM, Luthra HS, David CS. Collagen-induced arthritis in T cell receptor V beta congenic B10.Q mice. J Exp Med. 1994 Aug 1; 180(2):517-24.
    View PubMed
  66. Rhee RY, Gloviczki P, Luthra HS, Stanson AW, Bower TC, Cherry KJ Jr. Iliocaval complication of retroperitoneal fibrosis. Am J Surg. 1994 Aug; 168:179-183.
    View PubMed
  67. Gonzalez-Gay MA, Luthra HS, David CS. Collagen-induced arthritis: an experimental model for rheumatoid arthritis. [Spanish]. Rev Esp Reumatol. 1994; 21(8):329-333.
  68. Moder KG, Luthra HS, Griffiths M, David CS. Prevention of collagen induced arthritis in mice by deletion of T cell receptor V beta 8 bearing T cells with monoclonal antibodies. Br J Rheumatol. 1993 Jan; 32(1):26-30.
    View PubMed
  69. Griffiths MM, Cole BC, Ito J, Harper DS, Anderson GD, Cannon GW, Luthra HS, David CS. T-cell receptors and collagen induced arthritis in H-2r mice. Autoimmunity. 1993; 14(3):221-9.
    View PubMed
  70. Moder KG, Nabozny GH, Luthra HS, David CS. Immunogenetics of collagen induced arthritis in mice: a model for human polyarthritis. Reg Immunol. 1992 Sep-Oct; 4(5):305-13.
    View PubMed
  71. Luthra HS. Newer modalities in the treatment of rheumatoid arthritis. The Practice of Internal Medicine-1992 1992 May 11-15; 319-20.
  72. Moder KG, Luthra HS, Kubo R, Griffiths M, David CS. Prevention of collagen induced arthritis in mice by treatment with an antibody directed against the T cell receptor alpha beta framework. Autoimmunity. 1992; 11(4):219-24.
    View PubMed
  73. Anderson GD, Banerjee S, Luthra HS, David CS. Role of Mls-1 locus and clonal deletion of T cells in susceptibility to collagen-induced arthritis in mice. J Immunol. 1991 Aug 15; 147(4):1189-93.
    View PubMed
  74. Nickerson C, Luthra H, David C. Antigenic mimicry and autoimmune diseases. Int Rev Immunol. 1991; 7(3):205-24.
    View PubMed
  75. Luthra HS. Rheumatoid arthritis. Clinical Immunology Newsletter. 1990 Sep; 10:127-128.
  76. Luthra HS, David CS. Collagen-induced arthritis in mice: a model for human rheumatoid arthritis? Clinical Immunology Newsletter. 1990 Sep; 10:131-136.
  77. Nickerson CL, Luthra HS, Savarirayan S, David CS. Susceptibility of HLA-B27 transgenic mice to Yersinia enterocolitica infection. Hum Immunol. 1990 Aug; 28(4):382-96.
    View PubMed
  78. Nickerson CL, Luthra HS, David CS. Role of enterobacteria and HLA-B27 in spondyloarthropathies: studies with transgenic mice. Ann Rheum Dis. 1990 Jun; 49(1):426-33.
    View PubMed
  79. Gabriel SE, Conn DL, Luthra H. Rifampin therapy in rheumatoid arthritis. J Rheumatol. 1990 Feb; 17(2):163-6.
    View PubMed
  80. Luthra HS, David CS. Collagen induced arthritis in mice: a model for human rheumatoid arthritis? Clinical Immunology Newsletter. 1990; 10:131-136.
  81. Nickerson CL, Hogen KL, Luthra HS, David CS. Effect of H-2 genes on expression of HLA-B27 and Yersinia-induced arthritis. Scand J Rheumatol Suppl. 1990; 87:85-90, discussion 90.
    View PubMed
  82. Banerjee S, Anderson GD, Luthra HS, David CS. Influence of complement C5 and VB T cell receptor mutations on susceptibility to collagen-induced arthritis in mice. J Immunol. 1989 Apr 1; 142:2237-2243.
    View PubMed
  83. Haqqi TM, Banerjee S, Jones WL, Anderson GD, Behlke MA, Loh DY, Luthra HS, David CS. Identification of T-cell receptor VB deletion mutant mouse strain AU/SSJ (H-2Q) which is resistant to collagen-induced arthritis. Immunogenetics. 1989 Mar; 29:180-185.
    View PubMed
  84. Valente RM, Luthra HS, Robb RA. Quantitative analysis of joint images from patients with rheumatoid arthritis. Proceedings of the IEEE. 1989; 11:1971-1972.
  85. Banerjee S, Luthra HS, Moore SB, O'Fallon WM. Serum IgG anti-native type II collagen antibodies in rheumatoid arthritis: association with HLA DR4 and lack of clinical correlation. Clinical & Experimental Rheumatology. 1988 Oct-Dec; 6(4):373-80.
    View PubMed
  86. Banerjee S, Wei BY, Hillman K, Luthra HS, David CS. Immunosuppression of collagen-induced arthritis in mice with an anti-IL-2 receptor antibody. J Immunol. 1988 Aug 15; 141(4):1150-4.
    View PubMed
  87. Valente RM, Luthra HS, Robb RA. Computerized techniques for documenting roentgenograph change (XR) in patients with rheumatoid arthritis (RA). Arthritis Rheum. 1988 Apr; 31(Suppl):S78.
  88. Banerjee S, Haqqi TM, Luthra HS, Stuart JM, David CS. Possible role of V beta T cell receptor genes in susceptibility to collagen-induced arthritis in mice. J Exp Med. 1988 Mar 1; 167(3):832-9.
    View PubMed
  89. Gabriel SE, Luthra HS. Rheumatoid arthritis: can the long-term outcome be altered? Mayo Clin Proc. 1988 Jan; 63(1):58-68.
    View PubMed
  90. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988; 31:315-324.
    View PubMed
  91. Lakhanpal S, Ginsburg WW, Luthra HS, Hunder GG. Transient regional osteoporosis. A study of 56 cases and review of the literature. Ann Intern Med. 1987 Mar; 106(3):444-50.
    View PubMed
  92. Michet CJ Jr, Rakela J, Luthra HS. Auranofin-associated colitis and eosinophilia. Mayo Clin Proc. 1987 Feb; 62(2):142-4.
    View PubMed
  93. Luthra HS, Wooley PH, Dillon AM, Singh SK, Lafuse WP, Krco CJ, Huse A, Stuart JM, Griffiths MM, David CS. Immunogenetics of collagen-induced arthritis (CIA) in mice: a model of autoimmune disease. Ann N Y Acad Sci. 1986 Jul 30; 475:361-363.
  94. Hirahara F, Wooley PH, Luthra HS, Coulam CB, Griffiths MM, David CS. Collagen-induced arthritis and pregnancy in mice: the effects of pregnancy on collagen-induced arthritis and the high incidence of infertility in arthritic female mice. American Journal of Reproductive Immunology & Microbiology. 1986 Jun; 11(2):44-54.
    View PubMed
  95. O'Duffy JD, Luthra HS, Unni KK, Hyatt RE. Bronchiolitis in a rheumatoid arthritis patient receiving auranofin. Arthritis Rheum. 1986 Apr; 29(4):556-9.
    View PubMed
  96. Lakhanpal S, McLeod RA, Luthra HS. Insufficiency-type stress fractures in rheumatoid arthritis: report of an interesting case and review of the literature. Clinical & Experimental Rheumatology. 1986 Apr-Jun; 4(2):151-4.
    View PubMed
  97. Dillon AM, Luthra HS, Conn DL, Ferguson RH. Parenteral gold therapy in the Felty syndrome. Experience with 20 patients. Medicine (Baltimore) 1986 Mar; 65(2):107-12.
    View PubMed
  98. Michet CJ Jr, McKenna CH, Luthra HS, O'Fallon WM. Relapsing polychondritis. Survival and predictive role of early disease manifestations. Ann Intern Med. 1986 Jan; 104(1):74-8.
    View PubMed
  99. Prakash UB, Luthra HS, Divertie MB. Intrathoracic manifestations in mixed connective tissue disease. Mayo Clin Proc. 1985 Dec; 60(12):813-21.
    View PubMed
  100. del Junco DJ, Annegers JF, Luthra HS, Coulam CB, Kurland LT. Do oral contraceptives prevent rheumatoid arthritis? JAMA. 1985 Oct 11; 254(14):1938-41.
    View PubMed
  101. Wooley PH, Luthra HS, Griffiths MM, Stuart JM, Huse A, David CS. Type II collagen-induced arthritis in mice. IV. Variations in immunogenetic regulation provide evidence for multiple arthritogenic epitopes on the collagen molecule. J Immunol. 1985 Oct; 135(4):2443-51.
    View PubMed
  102. Lakhanpal S, Luthra HS. D-penicillamine in Felty's syndrome. J Rheumatol. 1985 Aug; 12(4):703-6.
    View PubMed
  103. Wooley PH, Luthra HS, Lafuse WP, Huse A, Stuart JM, David CS. Type II collagen-induced arthritis in mice. III. Suppression of arthritis by using monoclonal and polyclonal anti-Ia antisera. J Immunol. 1985 Apr; 134(4):2366-74.
    View PubMed
  104. Hall S, Buettner H, Luthra HS. Occlusive retinal vascular disease in systemic lupus erythematosus. J Rheumatol. 1984 Dec; 11(6):846-50.
    View PubMed
  105. Wooley PH, Luthra HS, Singh SK, Huse AR, Stuart JM, David CS. Passive transfer of arthritis to mice by injection of human anti-type II collagen antibody. Mayo Clin Proc. 1984 Nov; 59(11):737-43.
    View PubMed
  106. Wooley PH, Luthra HS, Krco CJ, Stuart JM, David CS. Type II collagen-induced arthritis in mice. II. Passive transfer and suppression by intravenous injection of anti-type II collagen antibody or free native type II collagen. Arthritis Rheum. 1984 Sep; 27(9):1010-7.
    View PubMed
  107. Lakhanpal S, Luthra HS. Pleuropulmonary manifestations of rheumatoid disease. Minn Med. 1984 Sep; 67(9):515-6.
    View PubMed
  108. Wooley PH, Luthra HS, O'Duffy JD, Bunch TW, Moore SB, Stuart JM. Anti-type II collagen antibodies in rheumatoid arthritis. The influence of HLA phenotype. Tissue Antigens. 1984 May; 23(5):263-9.
    View PubMed
  109. del Junco D, Luthra HS, Annegers JF, Worthington JW, Kurland LT. The familial aggregation of rheumatoid arthritis and its relationship to the HLA-DR4 association. Am J Epidemiol. 1984 May; 119(5):813-29.
    View PubMed
  110. O'Duffy JD, Luthra HS. Current status of disease-modifying drugs in progressive rheumatoid arthritis. Drugs. 1984 May; 27(5):373-7.
    View PubMed
  111. Scalapino J, Luthra HS. Raynaud's syndrome. Minn Med. 1984 Apr; 67(4):221-2.
    View PubMed
  112. Hall S, Luthra HS. Rheumatologic manifestations of amyloid disease. Minn Med. 1983 Oct; 66(10):631-2.
    View PubMed
  113. Persellin ST, Griffing WL, Michet CJ, Schroeder KW, Luthra HS. Polymyositis associated with jejunoileal bypass. J Rheumatol. 1983 Aug; 10(4):637-9.
    View PubMed
  114. Wooley PH, Dillon AM, Luthra HS, Stuart JM, David CS. Genetic control of type II collagen-induced arthritis in mice: factors influencing disease susceptibility and evidence for multiple MHC- associated gene control. Transplant Proc. 1983 Mar; 15(BOOK 1):180-185.
  115. Luthra HS, Dillion AM. Gold therapy for Felty's syndrome: current status. Intern Med Spec. 1983; 4:111-122.
  116. Dillon AM, Luthra HS. Lupus nephritis. Minn Med. 1982 Dec; 65(12):737-8.
    View PubMed
  117. Vollertsen RS, Fuster V, Conn DL, Luthra HS, McDuffie FC, Bowie EJ, Ilstrup DM. In vivo platelet survival in rheumatoid arthritis. Mayo Clin Proc. 1982 Oct; 57(10):620-4.
    View PubMed
  118. Jacobs AJ, Luthra HS. Intra-abdominal complications of systemic lupus erythematosus. Minn Med. 1982 Mar; 65(3):183-4.
    View PubMed
  119. Welch CL, Annesley TM, Luthra HS, Moyer TP. Liquid-chromatographic determination of zomepirac in serum and plasma. Clin Chem. 1982 Mar; 28(3):481-4.
    View PubMed
  120. Luthra HS, Conn DL, Ferguson RH. Felty's syndrome: response to parenteral gold. J Rheumatol. 1981 Nov-Dec; 8(6):902-9.
    View PubMed
  121. Wooley PH, Luthra HS, Stuart JM, David CS. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med. 1981 Sep 1; 154(3):688-700.
    View PubMed
  122. Herberman RB, Bordes M, Lambert PH, Luthra HS, Robins RA, Sizaret P, Theofilopoulos A. Report on international comparative evaluation of possible value of assays for immune complexes for diagnosis of human breast cancer. Int J Cancer. 1981 May 15; 27(5):569-76.
    View PubMed
  123. Luthra HS. Clinical brief: new oral gold compound. Mayo Clin Proc. 1981 Feb; 56:133.
  124. Luthra HS, McKenna CH, Terasaki PI. Lack of association of HLA-A and B locus antigens with relapsing polychondritis. Tissue Antigens. 1981; 17(4):442-3.
    View PubMed
  125. Luthra HS. Ankylosing spondylitis. Minn Med. 1980 Dec; 63(12):885-6.
    View PubMed
  126. Luthra HS. HLA and rheumatic disease. Minn Med. 1980 Sep; 63(9):657-61.
    View PubMed
  127. Griffing WL, Moore SB, Luthra HS, McKenna CH, Fathman CG. Associations of antibodies to native DNA with HLA-DRw3: a possible major histocompatibility complex-linked human immune response gene. J Exp Med. 1980 Aug; 152:319S-325S.
    View PubMed
  128. Sigmond E, Luthra HS. Carpal tunnel syndrome. Minn Med. 1980 Mar; 63(3):213.
    View PubMed
  129. Luthra HS. Extra-articular manifestations of rheumatoid arthritis. Minn Med. 1979 Oct; 62(10):743-4.
    View PubMed
  130. Gupta RC, McDuffie FC, Huston KA, Tappeiner G, Meurer M, Jordon RE, Luthra HS, Hunder GG, Ilstrup D. Comparison of three immunoassays for immune complexes in rheumatoid arthritis. Arthritis Rheum. 1979 May; 22(5):433-9.
    View PubMed
  131. Luthra HS. Rheumatology corner: examination of the arthritic patient. Minn Med. 1978 Oct; 61:589.
    View PubMed
  132. Luthra H. Aims of diagnosis and management of patients with arthritis. Minn Med. 1978 Jul; 61(7):436.
    View PubMed
  133. Samayoa EA, McDuffie FC, Nelson AM, Go VL, Luthra HS, Brumfield HW. Immunoglobulin complexes in sera of patients with malignancy. Int J Cancer. 1977 Jan; 19(1):12-7.
    View PubMed
  134. McKenna CH, Luthra HS, Jordon RE. Hypocomplementemic ear effusion in relapsing polychondritis. Mayo Clin Proc. 1976 Aug; 51(8):495-7.
    View PubMed
  135. Luthra HS, Ferguson RH, Conn DL. Coexistence of ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum. 1976 Jan-Feb; 19(1):111-4.
    View PubMed
  136. Luthra HS, Hunder GG. Spontaneous remission of Felty's syndrome. Arthritis Rheum. 1975 Sep-Oct; 18:515-517.
    View PubMed
  137. Luthra HS, McDuffie FC, Hunder GG, Samayoa EA. Immune complexes in sera and synovial fluids of patients with rheumatoid arthritis. J Clin Invest. 1975 Aug; 56:458-466.
    View PubMed